4D Molecular Therapeutics FDMT
NASDAQ FDMT
$14.49 -0.07 (-0.48%)
At close: Sep 29, 2026 · 4:00 PM EDT

4D Molecular Therapeutics (FDMT) Receivables - Other (2021)

Updated

4D Molecular Therapeutics (FDMT) reported Receivables - Other of $561,000 for Q1 2021.

Analysis

4D Molecular Therapeutics (FDMT) Receivables - Other (2021) Analysis & Trends

At the end of FY2020, 4D Molecular Therapeutics posted Receivables - Other of $169,000, up 13.4% from FY2019.

  • By year, Receivables - Other came in at $149,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 4D Molecular Therapeutics 1.02 Bn -436.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 561,000.00
API Access

4D Molecular Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=FDMT&period=max&api_key=YOUR_API_KEY